Skip to main content

Advertisement

Log in

Plasma ochratoxin A levels, food consumption, and risk biomarkers of a representative sample of men and women from the Molise region in Italy

  • Original Contribution
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Abstract

Background

Ochratoxin A (OTA) is a mycotoxin present in food that can be found in human blood, due to its long half-life. Plasma OTA detection represents a good parameter for evaluating the exposure at the population level.

Purpose

The relation between plasma OTA levels, dietary habits, and specific disease risk biomarkers (body mass index (BMI), C-reactive protein (CRP), and cardiovascular risk score) was investigated.

Methods

The study involved 327 subjects (150 men and 177 women) aged between 38 and 48 years. Food consumption was evaluated by means of the EPIC questionnaire; plasma OTA was measured by HPLC; CRP was determined in fresh serum samples by a latex particle-enhanced immunoturbidimetric assay.

Results

OTA was detected in 99.1% of plasma samples (LOD 25 ng/L); the mean ± SD value was 0.229 ± 0.238 ng/mL. However, only 5.2% of samples exceeded 500 ng/L, considered the threshold for a possible pathogenic activity. The estimated mean daily dietary intake of OTA resulted 0.452 ± 0.468 ng/kg body weight (bw)/day, markedly lower than the tolerable daily intake set by EFSA (17.1 ng/kg bw/day). Processed and mutton/lamb meat were found to contribute most to plasma OTA variance. Nevertheless, cereals, wine, beer, and jam/honey consumption correlated positively with OTA levels. Plasma OTA showed a significant positive association with CRP and cardiovascular risk score (β = 0.20 ± 0.08; P = 0.015 and β = 0.25 ± 0.08; P = 0.001, respectively); however, the association was present in men but not in women.

Conclusions

Even if the hypothesis of a possible hepatic toxicity of OTA in humans is yet to be verified, the positive association between plasma OTA and CRP may indicate a possible role of OTA in inflammation status and consequently in the genesis of cardiovascular diseases and cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

BMI:

Body mass index

bw:

Body weight

CRP:

C-reactive protein

CVD:

Cardiovascular disease

OTA:

Ochratoxin A

LOD:

Limit of detection

LOQ:

Limit of quantification

ROS:

Reactive oxygen species

RSD:

Relative standard deviation

TWI:

Tolerable weekly intake

References

  1. Battilani P, Pietri A, Bertuzzi T, Languasco L, Giorni P, Kozakiewicz Z (2003) Occurrence of ochratoxin A producing fungi in grape grown in Italy. J Food Prot 66:633–636

    Google Scholar 

  2. IARC (1993) IARC Monographs on the evaluation of carcinogenic risks to humans, some naturally occurring substances, Food Items and constituents, Heterocyclic aromatic amines and mycotoxins, vol 56. IARC Publications, Lyon

    Google Scholar 

  3. EFSA (2006) Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to ochratoxin A in food. EFSA J 365: 1–56. http://www.efsa.europa.eu/en/scdocs/doc/contam_op_ej365_ochratoxin_a_food_en.pdf. Accessed 3 May 2011

    Google Scholar 

  4. Okutan H, Aydin G, Ozcelik N (2004) Protective role of melatonin in ochratoxin A toxicity in rat heart and lung. J Appl Toxicol 24:505–512

    Article  CAS  Google Scholar 

  5. Galvano F, Ritieni A, Piva G, Pietri A (2005) Mycotoxins in the human food chain. In: Duarte-Diaz DE (ed) The mycotoxin blue book. Nottingham University Press, Nottingham, pp 187–224

    Google Scholar 

  6. Pfohl-leszkowicz A, Manderville RA (2007) Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 51:61–99

    Article  CAS  Google Scholar 

  7. FAO/WHO, Food and Agriculture Organisation/World Health Organisation (2001) Ochratoxin A. In: Safety evaluation of certain mycotoxins in food, Prepared by the 56th Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO Food Additives Series 47. World Health Organisation, Geneva, pp 281–387

  8. European Commission (2008) RASFF The Rapid Alert System for Food and Feed. Annual report. http://ec.europa.eu/food/food/rapidalert/report2008_en.pdf. Accessed 3 May 2011

  9. Studer-Rohr I, Schlatter J, Dietrich DR (2000) Kinetic parameters and intra-individual fluctuations of ochratoxin A plasma levels in humans. Arch Toxicol 74:499–510

    Article  CAS  Google Scholar 

  10. Scott PM (2005) Biomarkers of human exposure to ochratoxin A. Food Addit Contam 22:99–107

    Article  CAS  Google Scholar 

  11. Galvano F, Pietri A, Bertuzzi T, Gagliardi L, Ciotti S, Luisi S, Bognanno M, La Fauci L, Iacopino AM, Nigro F, Li Volti G, Vanella L, Giammanco G, Tina GL, Gazzolo D (2008) Maternal dietary habits and mycotoxins occurrence in mature human milk. Mol Nutr Food Res 52:496–501

    Article  CAS  Google Scholar 

  12. Turconi G, Guarcello M, Livieri C, Comizzoli S, Maccarini L, Castellazzi AM, Pietri A, Piva G, Roggi C (2004) Evaluation of xenobiotics in human milk and ingestion by the newborn-an epidemiological survey in Lombardy (Northern Italy). Eur J Nutr 43:191–197

    Article  CAS  Google Scholar 

  13. Biasucci G, Calabrese G, Di Giuseppe R, Carrara G, Colombo F, Mandelli B, Maj M, Bertuzzi T, Pietri A, Rossi F (2010) The presence of ochratoxin A in cord serum and in human milk and its correspondence with maternal dietary habits. Eur J Nutr 50:211–218

    Article  Google Scholar 

  14. Muñoz K, Blaszkewicz M, Degen GH (2010) Simultaneous analysis of ochratoxin A and its major metabolite ochratoxin alpha in plasma and urine for an advanced biomonitoring of the mycotoxin. J Chromatogr B Anal Technol Biomed Life Sci 878:2623–2629

    Article  Google Scholar 

  15. Iacoviello L, Bonanni A, Costanzo S, De Curtis A, Di Castelnuovo A, Olivieri M, Zito F, Donati MB, de Gaetano G on behalf of the Moli-sani Project Investigators (2007) The Moli-Sani Project, a randomized, prospective cohort study in the Molise region in Italy; design, rationale and objectives. Ital J Public Health 4:110–118

    Google Scholar 

  16. Pisani P, Faggiano F, Krogh V, Palli D, Vineis P, Berrino F (1995) Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol 26(1):S152–S160

    Article  Google Scholar 

  17. Pala V, Sieri S, Palli D, Salvini S, Berrino F, Bellegotti M, Frasca G, Tumino R, Sacerdote C et al (2003) Diet in the Italian EPIC cohorts: presentation of data and methodological issues. Tumori 89:594–607

    Google Scholar 

  18. Centritto F, Iacoviello L, di Giuseppe R, De Curtis A, Costanzo S, Zito F, Grioni S, Sieri S, Donati MB, de Gaetano G, Di Castelnuovo A (2009) Dietary patterns, cardiovascular risk factors and C-reactive protein in a healthy Italian population. Nutr Metab Cardiovasc Dis 19:697–706

    Article  CAS  Google Scholar 

  19. Giampaoli S, Palmieri L, Chiodini P, Cesana G, Ferrario M, Panico S et al (2004) The global cardiovascular risk chart. Ital Heart J Suppl 5:177–185

    Google Scholar 

  20. AOAC International (2005) Official methods of analysis. In: 18th ed Gaithersburg, MD, 49.06.01, method 973.37

  21. Willett W, Stampfer M (1998) Implications of total energy intake for epidemiologic analysis. In: Willett W (ed) Nutritional epidemiology, 2nd edn. Oxford University Press, New York, pp 273–301

    Chapter  Google Scholar 

  22. Dallal GE (2005) The little handbook of statistical practice. Available from: http://www.StatisticalPractice.com. Accessed 3 May 2011

  23. Pérez de Obanos A, Lopez de Cerain A, Jiménez AM, Gonzalez-Peñas E, Bello J (2001) Ochratoxin A in human plasma: new data of exposition in Spain. Rev Toxicol 18:19–23

    Google Scholar 

  24. Palli D, Miraglia M, Saieva C, Masala G, Cava E, Colatosti M, Corsi AM, Russo A, Brera C (1999) Serum levels of ochratoxin A in healthy adults in Tuscany: correlation with individual characteristics and between repeat measurements. Cancer Epidemiol Biomarkers Prev 8:265–269

    CAS  Google Scholar 

  25. Thuvander A, Paulsen JE, Axberg K, Johansson N, Vidnes A, Enghardt-Barbieri H, Trygg K, Lund-Larsen K, Jahrl S, Widenfalk A, Bosnes V, Alexandere J, Hult K, Olsen M (2001) Levels of ochratoxin A in blood from Norwegian and Swedish blood donors and their possible correlation with food consumption. Food Chem Toxicol 39:1145–1151

    Article  CAS  Google Scholar 

  26. Filali A, Betbeder AM, Baudrimont I, Benayada A, Soulaymani R, Creppy E (2002) Ochratoxin A in human plasma in Morocco: a preliminary survey. Hum Exp Toxicol 21:241

    Article  CAS  Google Scholar 

  27. Assaf H, Betbeder AM, Creppy EE, Pallardy M, Azouri H (2004) Ochratoxin A levels in human plasma and foods in Lebanon. Hum Exp Toxicol 23:495–501

    Article  CAS  Google Scholar 

  28. Zimmerli B, Dick R (1995) Determination of ochratoxin A at the ppt level in human blood, serum, milk and some foodstuffs by high-performance liquid chromatography with enhanced fluorescence detection and immunoaffinity column cleanup: methodology and Swiss data. J Chromatogr B 666:85–99

    Article  CAS  Google Scholar 

  29. Grosso F, Said S, Mabrouk I, Fremy JM, Castegnaro M, Jemmali M, Dragacci S (2003) New data on the occurrence of ochratoxin A in Human sera from patients affected or not by renal diseases in Tunisia. Food Chem Toxicol 41:1133–1140

    Article  CAS  Google Scholar 

  30. Hassen W, Abid S, Achour A, Creppy E, Bacha H (2004) Ochratoxin A and β2-microglobulinuria in healthy individuals and in chronic interstitial nephropathy patients in the Centre of Tunisia: a hot spot of Ochratoxin exposure. Toxicology 199:185–193

    Article  CAS  Google Scholar 

  31. Dinis AM, Lino CM, Pena AS (2007) Ochratoxin A in nephropathic patients from two cities of central zone in Portugal. J Pharm Biomed Anal 44:553–557

    Article  CAS  Google Scholar 

  32. Directorate-General Health and Consumer Protection of the European Commission (2002) Assessment of dietary intake of Ochratoxin A by the population of EU Member States—Report of experts participating in Task 3.2.7. In: Miraglia M, Brera C (eds) Reports on tasks for scientific cooperation; http://ec.europa.eu/food/fs/scoop/index_en.html. Accessed 3 May 2011

  33. Blank R, Rolfs JP, Sudekum KH, Frohlich AA, Marquardt RR, Wolffram S (2003) Effects of chronic ingestion of ochratoxin A on blood levels and excretion of the mycotoxin in sheep. J Agric Food Chem 51(23):6899–6905

    Article  CAS  Google Scholar 

  34. Majerus R, Bresch H, Otteneder H (2000) Ochratoxin A in wines, fruit juices and seasonings. Arch Lebensmittelhyg 51(4/5):95–97

    CAS  Google Scholar 

  35. Galvano F, Piva A, Ritieni A, Galvano G (2001) Dietary strategies to counteract the effects of mycotoxins: a review. J Food Prot 64:120–131

    CAS  Google Scholar 

  36. Surai PF (2002) In: Natural antioxidant in avian nutrition and reproduction. Nottingham University Press, UK

  37. Grosse Y, Chekir-Ghedira L, Huc A, Obrecht-Pflumio S, Dirheimer G, Bacha H, Pfohl-Leszkowicz A (1997) Retinol, ascorbic acid and alpha-tocopherol prevent DNA adduct formation in mice with the mycotoxins ochratoxin A and zearalenone. Cancer Lett 114:225–229

    Article  CAS  Google Scholar 

  38. Baldi A, Losio MN, Cheli F, Rebucci R, Sangalli L, Fusi E, Bertasi B, Pavoni E, Carli S, Politis I (2004) Evaluation of the protective effects of alpha-tocopherol and retinol against ochratoxin a cytotoxicity. Br J Nutr 91(4):507–512

    Article  CAS  Google Scholar 

  39. Nanri A, Moore MA, Kono S (2007) Impact of C-reactive protein on disease risk and its relation to dietary factors. Asian Pac J Cancer Prev 8(2):167–177

    Google Scholar 

  40. Soyöz M, Ozçelik N, Kilinç I, Altuntaş I (2004) The effects of ochratoxin A on lipid peroxidation and antioxidant enzymes: a protective role of melatonin. Cell Biol Toxicol 20(4):213–219

    Article  Google Scholar 

  41. Gagliano N, Donne ID, Torri C, Migliori M, Grizzi F, Milzani A, Filippi C, Annoni G, Colombo P, Costa F, Ceva-Grimaldi G, Bertelli AA, Giovannini L, Gioia M (2006) Early cytotoxic effects of ochratoxin A in rat liver: a morphological, biochemical and molecular study. Toxicology 225(2–3):214–224

    Article  CAS  Google Scholar 

  42. Hundhausen C, Bösch-Saadatmandi C, Augustin K, Blank R, Wolffram S, Rimbach G (2005) Effect of vitamin E and polyphenols on ochratoxin A-induced cytotoxicity in liver (HepG2) cells. J Plant Physiol 162(7):818–822

    Article  CAS  Google Scholar 

  43. El Golli Bennour E, Rodriguez-Enfedaque A, Bouaziz C, Ladjimi M, Renaud F, Bacha H (2009) Toxicities induced in cultured human hepatocarcinoma cells exposed to ochratoxin A: oxidative stress and apoptosis status. J Biochem Mol Toxicol 23(2):87–96

    Article  CAS  Google Scholar 

  44. Petkova-Bocharova T, Chernozemsky IN, Castegnaro M (2002) Balkan endemic nephropathy and associate durinary tract tumours: a review on aetiological causes and the potential role of mycotoxins. Food Add Contam 19:282–302

    Article  Google Scholar 

  45. Arlt VM, Ferluga D, Stiborova M, Pfohl-Leszkowicz A, Vukelic M, Ceovic S, Schmeiser HH, Cosyns JP (2002) Is aristolochic acid a risk factor for Balkan endemic nephropthy-associated urothelial cancer ? Int J Cancer 101:500–502

    Article  CAS  Google Scholar 

  46. Suzuki S, Moroi K, Kanisawa M, Satoh T (1986) Effects of drug metabolizing enzyme inducers on carcinogenesis and toxicity of ochratoxin A in mice. Toxicol Lett 31(Suppl.):206

    Google Scholar 

  47. Kanisawa M, Suzuki S (1978) Induction of renal and hepatic tumors in mice by ochratoxin A; a mycotoxin. Gann 69:599–600

    CAS  Google Scholar 

  48. Heikkilä K, Harris R, Lowe G, Rumley A, Yarnell J, Gallacher J, Ben-Shlomo Y, Ebrahim S, Lawlor DA (2009) Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Cause Control 20(1):15–26

    Article  Google Scholar 

  49. Trichopoulus D, Psaltopoulou T, Orfanos P, Trichopoulou A, Boffetta P (2006) Plasma C-reactive protein and risk cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev 15(2):381–384

    Article  Google Scholar 

  50. Allin KH, Nordestgaard BG, Zacho J, Tybjaerg-Hansen A, Bojesen SE (2010) C-reactive protein and the risk of cancer: a mendelian randomization study. J Natl Cancer Inst 102(3):202–206

    Article  CAS  Google Scholar 

  51. Hussein AA, Arbid MS (2002) Circulatory disorders induced by ochratoxin A. Egyptian J Biol 4:147–156

    Google Scholar 

Download references

Acknowledgments

This work was supported by Fondazione Romeo ed Enrica Invernizzi, Milano, Italia.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Filippo Rossi.

Appendix

Appendix

See Table 5.

Table 5 Food items included in each food groups

Rights and permissions

Reprints and permissions

About this article

Cite this article

di Giuseppe, R., Bertuzzi, T., Rossi, F. et al. Plasma ochratoxin A levels, food consumption, and risk biomarkers of a representative sample of men and women from the Molise region in Italy. Eur J Nutr 51, 851–860 (2012). https://doi.org/10.1007/s00394-011-0265-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-011-0265-5

Keywords

Navigation